Teva Pharmaceutical Industries Ltd. announced it is settling several lawsuits related to Medicaid reimbursement for its products, and setting aside $315 million to cover the settlement and other suits.

Teva did not say how much it will pay to resolve the lawsuits and how much will be placed in reserve. The Israeli company, the world’s largest manufacturer of generic drugs, said the settlement would endlawsuits brought by the U.S. government and the states of Florida, Texas, and California. The lawsuits alleged that Teva inflated the prices of products to receive higher reimbursements from Medicaid programs.

The settlement would end the claims against Teva by the federal government and three states. Fifteen states had filed suit against Teva concerning Medicaid reimbursement.

In its announcement Teva indicated that other pharmaceutical manufacturers are defendants in the civil suits over drug pricing.